Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

The changing of the guard.

Rodby R, Perazella MA, Berns JS.

Semin Dial. 2019 Nov;32(6):482-484. doi: 10.1111/sdi.12843. Epub 2019 Oct 21. No abstract available.

PMID:
31633841
2.

The Case | Unexplained stupor with a high osmolal and high anion gap metabolic acidosis.

Zakaryan V, Rodby RA.

Kidney Int. 2019 Sep;96(3):799-800. doi: 10.1016/j.kint.2019.02.026. No abstract available.

PMID:
31445589
3.

Pseudo-anion gap metabolic acidosis from severe hypertriglyceridemia corrected by plasma exchangeā€©.

Carag C, Baxi PV, Behara V, Gashti CN, Rodby R.

Clin Nephrol. 2019 Nov;92(5):258-262. doi: 10.5414/CN109627.

PMID:
31347495
4.

When Monoclonal Gammopathy is of Renal Significance: A Case Study of Crystalglobulinemia From Chicago Multiple Myeloma Rounds.

Gilmore BA, Rodby RA, Cimbaluk D, Venugopal P, Patel P, Barton K, Hagen P, Rodriguez T, Sumoza L, Bishop MR, Dhakal B, Hari P, Paner A.

Clin Lymphoma Myeloma Leuk. 2019 Jun;19(6):e251-e258. doi: 10.1016/j.clml.2019.02.008. Epub 2019 Mar 8. No abstract available.

PMID:
30987953
5.

The Glomerular Disease Study and Trial Consortium: A Grassroots Initiative to Foster Collaboration and Innovation.

Poyan Mehr A, Sadeghi-Najafabadi M, Chau K, Messmer J, Pai R, Roy N, Friedman D, Pollak MR, Schlondorff J, Naljayan M, Singh T, Lecker SH, Rodby R, Germain M, Rennke H, Stillman IE.

Kidney Int Rep. 2018 Sep 21;4(1):20-29. doi: 10.1016/j.ekir.2018.09.012. eCollection 2019 Jan. Review.

6.

Changing Trends in the Performance of Percutaneous Renal Biopsy from Nephrologist to Interventional Radiologist: A Single-Center Experience.

Korbet SM, Whittier WL, Rodby RA.

Am J Nephrol. 2018;48(5):326-329. doi: 10.1159/000493925. Epub 2018 Oct 24.

7.

When the HeRO Becomes the Villain.

Onkka P, Rodby R.

Semin Dial. 2017 Sep;30(5):456-457. doi: 10.1111/sdi.12619. Epub 2017 Jun 13. No abstract available.

PMID:
28608938
8.

Timed Urine Collections for Albumin and Protein: "The King Is Dead, Long Live the King!"

Rodby RA.

Am J Kidney Dis. 2016 Dec;68(6):836-838. doi: 10.1053/j.ajkd.2016.06.025. Epub 2016 Sep 16. No abstract available.

PMID:
27646424
9.

Mistakes We Make in Dialysis: An Introduction.

Rodby RA, Perazella MA.

Semin Dial. 2016 Jul;29(4):257. doi: 10.1111/sdi.12485. Epub 2016 Apr 8. No abstract available.

PMID:
27061177
10.

Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial Data.

Rodby RA, Umanath K, Niecestro R, Bond TC, Sika M, Lewis J, Dwyer JP; Collaborative Study Group.

Drugs R D. 2015 Sep;15(3):271-9. doi: 10.1007/s40268-015-0103-y.

11.

How Does a Patient's Primary Renal Disease Impact Chronic Dialysis Management?: Diseases Treated with Immunosuppressive Agents.

Rodby RA.

Semin Dial. 2015 Sep-Oct;28(5):466-8. doi: 10.1111/sdi.12399. Epub 2015 May 21. Review. No abstract available.

PMID:
25997800
12.

Elevated serum creatinine in a patient with normal renal function: the value of Cystatin C.

Sahota S, Rodby RA, Korbet SM.

Nephrology (Carlton). 2015 May;20(5):383-4. doi: 10.1111/nep.12399. No abstract available.

PMID:
25872661
13.

Inpatient hemodialysis without anticoagulation in adults.

Sahota S, Rodby R.

Clin Kidney J. 2014 Dec;7(6):552-6. doi: 10.1093/ckj/sfu114. Epub 2014 Oct 30.

14.

Phosphorus binding with ferric citrate is associated with fewer hospitalizations and reduced hospitalization costs.

Rodby R, Umanath K, Niecestro R, Jackson JH, Sika M, Lewis JB, Dwyer JP; Collaborative Study Group.

Expert Rev Pharmacoecon Outcomes Res. 2015 Jun;15(3):545-50. doi: 10.1586/14737167.2015.995169. Epub 2014 Dec 13.

PMID:
25495878
15.

Ferric citrate spans mineral metabolism and anemia domains in ESRD: a review of efficacy and safety data.

Sinsakul M, Rodby R, Umanath K, Niecestro R, Dwyer JP.

Expert Rev Clin Pharmacol. 2014 Nov;7(6):705-10. doi: 10.1586/17512433.2014.960848. Epub 2014 Sep 22. Review.

PMID:
25242077
16.

Common clinical quandaries encountered by nephrologists: more questions answered.

Rodby RA, Perazella MA.

Semin Dial. 2014 May-Jun;27(3):221-2. doi: 10.1111/sdi.12234. No abstract available.

PMID:
24758265
17.

Spot PC ratio estimates of 24-hour proteinuria are more unreliable in lupus nephritis than in other forms of chronic glomerular disease.

Birmingham DJ, Shidham G, Perna A, Fine DM, Bissell M, Rodby R, Remuzzi G, Petri M, Hebert P, Rovin BH, Hebert LA.

Ann Rheum Dis. 2014 Feb;73(2):475-6. doi: 10.1136/annrheumdis-2013-203790. Epub 2013 Oct 3. No abstract available.

18.

Accuracy of a GFR estimating equation over time in people with a wide range of kidney function.

Padala S, Tighiouart H, Inker LA, Contreras G, Beck GJ, Lewis J, Steffes M, Rodby RA, Schmid CH, Levey AS.

Am J Kidney Dis. 2012 Aug;60(2):217-24. doi: 10.1053/j.ajkd.2012.01.024. Epub 2012 Apr 10.

19.

Disease-specific patient reported outcome tools for systemic lupus erythematosus.

Jolly M, Pickard AS, Block JA, Kumar RB, Mikolaitis RA, Wilke CT, Rodby RA, Fogg L, Sequeira W, Utset TO, Cash TF, Moldovan I, Katsaros E, Nicassio P, Ishimori ML, Kosinsky M, Merrill JT, Weisman MH, Wallace DJ.

Semin Arthritis Rheum. 2012 Aug;42(1):56-65. doi: 10.1016/j.semarthrit.2011.12.005. Epub 2012 Apr 4.

PMID:
22480408
20.

Effects of high blood flow and high pre-dilution replacement fluid rates on small solute clearances in hemofiltration.

Gashti CN, Rodby RA, Huang Z, Gao D, Zhang W.

Blood Purif. 2011;32(4):266-70. doi: 10.1159/000328740. Epub 2011 Aug 24.

PMID:
21865724
21.

Common clinical quandaries encountered in dialysis and ESRD: questions answered.

Perazella MA, Rodby RA.

Semin Dial. 2011 Jul-Aug;24(4):363. doi: 10.1111/j.1525-139X.2011.00952.x. No abstract available.

PMID:
21851389
22.

Can gadolinium be given safely to a patient on dialysis?

Rodby RA.

Semin Dial. 2011 Jul-Aug;24(4):370-1. doi: 10.1111/j.1525-139X.2011.00895.x. Epub 2011 Jul 29. No abstract available.

PMID:
21801214
23.

Unexpectedly severe metabolic acidosis associated with sodium thiosulfate therapy in a patient with calcific uremic arteriolopathy.

Selk N, Rodby RA.

Semin Dial. 2011 Jan-Feb;24(1):85-8. doi: 10.1111/j.1525-139X.2011.00848.x.

PMID:
21338397
24.

Equations to estimate creatinine excretion rate: the CKD epidemiology collaboration.

Ix JH, Wassel CL, Stevens LA, Beck GJ, Froissart M, Navis G, Rodby R, Torres VE, Zhang YL, Greene T, Levey AS.

Clin J Am Soc Nephrol. 2011 Jan;6(1):184-91. doi: 10.2215/CJN.05030610. Epub 2010 Oct 21.

25.

LupusQoL-US benchmarks for US patients with systemic lupus erythematosus.

Jolly M, Pickard SA, Mikolaitis RA, Rodby RA, Sequeira W, Block JA.

J Rheumatol. 2010 Sep;37(9):1828-33. doi: 10.3899/jrheum.091443. Epub 2010 Aug 17.

PMID:
20716659
26.

Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations.

Stevens LA, Nolin TD, Richardson MM, Feldman HI, Lewis JB, Rodby R, Townsend R, Okparavero A, Zhang YL, Schmid CH, Levey AS; Chronic Kidney Disease Epidemiology Collaboration.

Am J Kidney Dis. 2009 Jul;54(1):33-42. doi: 10.1053/j.ajkd.2009.03.008. Epub 2009 May 17.

27.

Laparoscopy in the early diagnosis and management of sclerosing encapsulating peritonitis.

Kropp J, Sinsakul M, Butsch J, Rodby R.

Semin Dial. 2009 May-Jun;22(3):304-7. doi: 10.1111/j.1525-139X.2008.00546.x. Epub 2009 Apr 5.

PMID:
19386074
28.

Accelerated venovenous hemofiltration: early technical and clinical experience.

Gashti CN, Salcedo S, Robinson V, Rodby RA.

Am J Kidney Dis. 2008 May;51(5):804-10. doi: 10.1053/j.ajkd.2008.01.012. Epub 2008 Mar 25.

PMID:
18436091
29.

A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.

Palmer AJ, Valentine WJ, Chen R, Mehin N, Gabriel S, Bregman B, Rodby RA.

Nephrol Dial Transplant. 2008 Apr;23(4):1216-23. doi: 10.1093/ndt/gfn082.

PMID:
18359872
30.

Dialytic therapies to prevent NSF following gadolinium exposure in high-risk patients.

Rodby RA.

Semin Dial. 2008 Mar-Apr;21(2):145-9. doi: 10.1111/j.1525-139X.2007.00405.x. Epub 2008 Jan 23. Review.

PMID:
18226002
31.

A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease.

Sinsakul M, Sika M, Rodby R, Middleton J, Shyr Y, Chen H, Han E, Lehrich R, Clyne S, Schulman G, Harris R, Lewis J.

Am J Kidney Dis. 2007 Dec;50(6):946-51.

PMID:
18037095
32.

Cost-effectiveness of irbesartan 300 mg given early versus late in patients with hypertension and a history of type 2 diabetes and renal disease: a Canadian perspective.

Coyle D, Rodby R, Soroka S, Levin A, Muirhead N, de Cotret PR, Chen R, Palmer A.

Clin Ther. 2007 Jul;29(7):1508-23.

PMID:
17825702
33.

Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney disease.

Perazella MA, Rodby RA.

Am J Med. 2007 Jul;120(7):561-2. No abstract available.

PMID:
17602923
34.

Gadolinium use in patients with kidney disease: a cause for concern.

Perazella MA, Rodby RA.

Semin Dial. 2007 May-Jun;20(3):179-85. Review.

PMID:
17555477
35.

Preventing complications of radiographic contrast media: is there a role for dialysis?

Rodby RA.

Semin Dial. 2007 Jan-Feb;20(1):19-23. Review.

PMID:
17244114
36.

A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 diabetes and hypertension.

Palmer AJ, Valentine WJ, Tucker DM, Ray JA, Roze S, Annemans L, Lapuerta P, Chen R, Gabriel S, Carita P, Rodby RA, de Zeeuw D, Parving HH, Laville M.

Curr Med Res Opin. 2006 Nov;22(11):2095-100.

PMID:
17076969
37.

[Clinical and health economic implications of early treatment with irbesartan of patients with type 2 diabetes mellitus, hypertension and nephropathy].

Palmer AJ, Roze S, Rodby RA, Valentine WJ, Ritz E, Lehnert H.

Dtsch Med Wochenschr. 2006 Aug 4;131(31-32):1721-6. German.

PMID:
16868875
38.

Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations.

Pohl MA, Blumenthal S, Cordonnier DJ, De Alvaro F, Deferrari G, Eisner G, Esmatjes E, Gilbert RE, Hunsicker LG, de Faria JB, Mangili R, Moore J Jr, Reisin E, Ritz E, Schernthaner G, Spitalewitz S, Tindall H, Rodby RA, Lewis EJ.

J Am Soc Nephrol. 2005 Oct;16(10):3027-37. Epub 2005 Aug 24.

39.

Irbesartan is projected to be cost and life saving in a Spanish setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuria.

Palmer AJ, Annemans L, Roze S, Lapuerta P, Chen R, Gabriel S, Carita P, Rodby RA, de Zeeuw D, Parving HH, De Alvaro F.

Kidney Int Suppl. 2005 Jan;(93):S52-4.

PMID:
15613069
40.
41.

Pharmacoeconomic challenges in the management of diabetic nephropathy.

Rodby RA.

J Manag Care Pharm. 2004 Sep;10(5 Suppl A):S6-11.

42.

[Cost-efectiveness of Ibersartan in type II diabetic nephropathy with hypertension. A Spanish perspective].

Palmer AJ, Annemans L, Roze S, Lamotte M, Rodby RA, de Alvaro F; Grupo de Estudio Colaborativo IDNT.

Nefrologia. 2004;24(3):231-8. Spanish.

44.

An economic evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK setting.

Palmer AJ, Annemans L, Roze S, Lamotte M, Rodby RA, Bilous RW.

J Hum Hypertens. 2004 Oct;18(10):733-8.

PMID:
15116142
46.

[Health economic consequences of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension].

Palmer AJ, Annemans L, Roze S, Lamotte M, Rodby RA, Ritz E.

Dtsch Med Wochenschr. 2004 Jan 2;129(1-2):13-8. German.

PMID:
14703575
48.

The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathy.

Rodby RA, Chiou CF, Borenstein J, Smitten A, Sengupta N, Palmer AJ, Roze S, Annemans L, Simon TA, Chen RS, Lewis EJ; Collaborative Study Group.

Clin Ther. 2003 Jul;25(7):2102-19.

PMID:
12946554
49.

Aliquot versus batch sampling methods for measurements of peritoneal dialysis adequacy in patients receiving CAPD.

Rodby RA, Firanek CA.

Perit Dial Int. 2003 Jan-Feb;23(1):87-9. No abstract available.

PMID:
12691515
50.

A clinical trial in type 2 diabetic nephropathy.

Lewis EJ, Hunsicker LG, Rodby RA; Collaborative Study Group.

Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S191-4.

PMID:
11576953

Supplemental Content

Support Center